Literature DB >> 1988835

Monoclonal antibodies and the treatment of gram-negative bacteremia and shock.

S M Wolff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988835     DOI: 10.1056/NEJM199102143240709

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  More on pathogenesis and treatment of septic shock.

Authors:  D Fumarola; S Pece
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

Review 2.  Immunomodulators. Future prospects.

Authors:  B C Takx-Köhlen
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

3.  Anonymised screening for HIV: first results.

Authors:  T Delamothe
Journal:  BMJ       Date:  1991-05-25

4.  Delaying approval of a critical drug: safety, efficacy, economics, compassion.

Authors:  Leo T Rosenberg
Journal:  J Med Humanit       Date:  1994

5.  Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.

Authors:  A Ashkenazi; S A Marsters; D J Capon; S M Chamow; I S Figari; D Pennica; D V Goeddel; M A Palladino; D H Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

6.  Biochemical and electron microscopy analysis of the endotoxin binding to microtubules in vitro.

Authors:  C Risco; J E Domínguez; M A Bosch; J L Carrascosa
Journal:  Mol Cell Biochem       Date:  1993-04-07       Impact factor: 3.396

Review 7.  Antiendotoxin monoclonal antibodies. What future now?

Authors:  G M Susla; R B Dew
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

8.  Proteolytic activity and fatal gram-negative sepsis in burned mice: effect of exogenous proteinase inhibition.

Authors:  A N Neely; R G Miller; I A Holder
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

Review 9.  Organ-specific support in multiple organ failure: pulmonary support.

Authors:  P S Barie
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

Review 10.  Antibody-based therapies for emerging infectious diseases.

Authors:  A Casadevall
Journal:  Emerg Infect Dis       Date:  1996 Jul-Sep       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.